Russia's Rushed Vaccine Stands Up to Peer Review for Safety and Efficacy

After months of touting its efficacy to the western world, the efficacy of Russia’s Sputnik V vaccine has been validated in a peer-reviewed study published in The Lancet.

The prestigious journal published an interim analysis of Phase III data for the Russian-made vaccine that showed the preventative medicine generated an efficacy of 91.6% against the original strain of the virus. Only two other vaccines currently authorized against COVID-19 have shown higher efficacy. The mRNA vaccines developed by Moderna and Pfizer and BioNTech have demonstrated a 94% and 95% efficacy, respectively.